Motley Fool Australia
  •  
  • Log Out
  • Menu
  1. Stocks
    2. /
  2. Medibank Pvt Ltd (ASX: MPL)
    3. /

Medibank Pvt Ltd (ASX: MPL) Share Price and News

Price

$4.915

Movement

0.035 (+0.72%)

As at 12 Jun 2:53pm (20 mins delayed)

52 Week Range

$3.53 - $4.96

 
1 Year Return

+32.48%

Medibank Pvt Ltd Chart and Price Data

2025
2025
2025
2025
$3
$4
$5
$3
$4
$5
$3
$4
$5
$3
$4
$5

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $13.44 billion
P/E Ratio 27.53
Dividend Yield 3.51%
Shares Outstanding 2.75 billion
Earnings per share 0.178
Dividend per share 0.16
Year To Date Return 31.35%
Earnings Yield 3.63%
Franking 100%
Earnings Yield

3.63%

Franking

100%

Dividend per share

0.16

Year To Date Return

31.35%

Shares Outstanding

2.75 billion

Earnings per share

0.178

Share Price

$4.915

Day Change

0.035 (+0.72%)

52 Week Range

$3.53 - $4.96

Yesterday's Close

$4.88

Today's Open

$4.91

Days Range

$4.89 - $4.93

Volume

1,641,086

Avg. Volume (1 month)

5,979,010

Turnover

$8,065,402

As at 12 Jun 2:53pm

    • Medibank Pvt Ltd (ASX: MPL)
    Latest News

    a woman
    Investing

    3 big names I'm avoiding in 2017

    | Sean O'Neill

    Here's why I'm not a fan of Medibank Private Ltd (ASX:MPL), Inghams Group Ltd (ASX:ING), and Origin Energy Ltd (ASX:ORG)…

    Read more »

    a woman
    Investing

    3 blue-chip shares I'm avoiding in 2017

    | Ryan Newman (TMFNewmy)

    Not every blue-chip share is a buy…

    Read more »

    a woman
    Investing

    3 reasons I'm not buying Medibank Private Ltd shares in 2017

    | Sean O'Neill

    Buyers of Medibank Private Ltd (ASX:MPL) today aren't getting that good a deal.

    Read more »

    a woman
    Investing

    2 blue chips with big dividends I'd buy with $10,000 today

    | Tristan Harrison

    Crown Resorts Ltd (ASX:CWN) and Medibank Private Ltd (ASX:MPL) could be great additions to your dividend portfolio.

    Read more »

    a woman
    Investing

    Why I think Medibank Private Ltd won't win from higher interest rates

    | Sean O'Neill

    Shares in Medibank Private Ltd (ASX:MPL) are up since Trump's election – but should they be?

    Read more »

    a woman
    Investing

    3 healthcare stocks on my watchlist for a great 2017

    | Tristan Harrison

    NIB Holdings Limited (ASX:NHF) and CSL Limited (ASX:CSL) are 2 of 3 healthcare stocks that look like strong buys for…

    Read more »

    a woman
    Investing

    5 dividend shares on my watch list for 2017

    | Tristan Harrison

    Medibank Private Ltd (ASX:MPL) and WAM Research Limited (ASX:WAX) are 2 of 5 dividend shares for any portfolio.

    Read more »

    a woman
    Investing

    Why I think you should sell these 3 shares today

    | Rachit Dudhwala

    Commonwealth Bank of Australia (ASX:CBA), Medibank Private Ltd (ASX:MPL) and Fortescue Metals Group Limited (ASX:FMG) are ripe for profit taking.

    Read more »

    a woman
    Investing

    What everybody needs to know before buying Medibank Private Ltd shares

    | Sean O'Neill

    Shares in Medibank Private Ltd (ASX:MPL) are down today after the company's investor day presentation.

    Read more »

    a woman
    Investing

    ASX 200 to lift: 13 shares you need to watch today

    | Ryan Newman (TMFNewmy)

    Vocus Communications Limited (ASX:VOC) will remain in the spotlight today.

    Read more »

    a woman
    Investing

    Is Medibank Private Ltd going back to $3?

    | Sean O'Neill

    Investors should be very specific in their expectations for Medibank Private Ltd (ASX:MPL), and not buy it if it doesn't…

    Read more »

    a woman
    Investing

    The Medibank Private Ltd share price is sinking on its 'challenging' environment

    | Sean O'Neill

    Medibank Private Ltd (ASX:MPL) updated the market on its prospects this morning.

    Read more »

    Frequently Asked Questions

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    06 Mar 2025 $0.0780 100.00% Interim 26 Mar 2025
    04 Sep 2024 $0.0940 100.00% Final 26 Sep 2024
    29 Feb 2024 $0.0720 100.00% Interim 20 Mar 2024
    13 Sep 2023 $0.0830 100.00% Final 05 Oct 2023
    02 Mar 2023 $0.0630 100.00% Interim 22 Mar 2023
    07 Sep 2022 $0.0730 100.00% Final 29 Sep 2022
    04 Mar 2022 $0.0610 100.00% Interim 24 Mar 2022
    08 Sep 2021 $0.0690 100.00% Final 30 Sep 2021
    03 Mar 2021 $0.0580 100.00% Interim 25 Mar 2021
    02 Sep 2020 $0.0630 100.00% Final 24 Sep 2020
    03 Mar 2020 $0.0570 100.00% Interim 26 Mar 2020
    04 Sep 2019 $0.0740 100.00% Final 26 Sep 2019
    05 Mar 2019 $0.0570 100.00% Interim 28 Mar 2019
    05 Sep 2018 $0.0720 100.00% Final 27 Sep 2018
    06 Mar 2018 $0.0550 100.00% Interim 28 Mar 2018
    06 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.0525 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.0600 100.00% Final 28 Sep 2016
    04 Mar 2016 $0.0500 100.00% Interim 29 Mar 2016

    MPL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    16th May 2025 2025-05-16T16:34:00 Change in substantial holdingYesNo4:34pm3202k
    16th May 2025 2025-05-16T08:50:32 FY25 Full Year - Key DatesYesNo8:50am1217k
    6th May 2025 2025-05-06T08:28:41 Medibank shares business update and healthcare insightsYesNo8:28am3232k
    4th Apr 2025 2025-04-04T12:45:30 2022 cybercrime event - consumer class actionYesNo12:45pm1187k
    3rd Apr 2025 2025-04-03T08:22:43 Notification of cessation of securities - MPLYesNo8:22am413k
    25th Mar 2025 2025-03-25T16:37:19 Becoming a substantial holderYesNo4:37pm6307k
    27th Feb 2025 2025-02-27T08:08:25 HY25 Results - Investor PresentationYesNo8:08am371.8M
    27th Feb 2025 2025-02-27T08:08:10 HY25 Results - Media ReleaseYesNo8:08am5167k
    27th Feb 2025 2025-02-27T08:07:55 Dividend/Distribution - MPLYesNo8:07am414k
    27th Feb 2025 2025-02-27T08:07:40 HY25 Results - Appendix 4D and Financial ReportYesNo8:07am27523k

    About Medibank Pvt Ltd

    Previously owned by the Australian government, Medibank Private Ltd (ASX: MPL) is the largest health insurer in Australia.

    As of November 2022, its two brands, Medibank Private and ahm, provide cover to almost five million people.

    Medibank and Australia's fourth-largest health fund, NIB Holdings Limited (ASX: NIB), are the only health insurers listed on the ASX.

    In addition to private health insurance, the company provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.

    MPL Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    10 Jun 2025 $4.90 $0.05 1.03% 4,091,030 $4.85 $4.91 $4.84
    06 Jun 2025 $4.85 $-0.05 -1.02% 3,917,625 $4.92 $4.95 $4.84
    05 Jun 2025 $4.90 $0.02 0.41% 6,110,210 $4.86 $4.90 $4.85
    04 Jun 2025 $4.88 $-0.08 -1.61% 7,492,079 $4.95 $4.95 $4.85
    03 Jun 2025 $4.96 $0.09 1.85% 8,956,339 $4.90 $4.96 $4.87
    02 Jun 2025 $4.87 $0.10 2.10% 5,568,708 $4.78 $4.90 $4.78
    30 May 2025 $4.77 $-0.05 -1.04% 22,179,123 $4.79 $4.83 $4.76
    29 May 2025 $4.82 $0.01 0.21% 3,829,352 $4.82 $4.85 $4.80
    28 May 2025 $4.81 $-0.03 -0.62% 6,464,544 $4.83 $4.85 $4.79
    27 May 2025 $4.84 $0.01 0.21% 4,605,538 $4.82 $4.85 $4.81
    26 May 2025 $4.83 $0.01 0.21% 3,593,113 $4.79 $4.86 $4.79
    23 May 2025 $4.82 $-0.01 -0.21% 2,846,797 $4.82 $4.85 $4.81
    22 May 2025 $4.83 $0.01 0.21% 4,484,778 $4.80 $4.85 $4.79
    21 May 2025 $4.82 $0.07 1.47% 7,744,030 $4.80 $4.83 $4.76
    20 May 2025 $4.75 $-0.01 -0.21% 3,892,036 $4.78 $4.78 $4.73
    19 May 2025 $4.76 $0.02 0.42% 3,469,060 $4.71 $4.78 $4.69
    16 May 2025 $4.74 $0.01 0.21% 3,864,555 $4.77 $4.79 $4.72
    15 May 2025 $4.73 $0.03 0.64% 5,575,349 $4.71 $4.73 $4.68
    14 May 2025 $4.70 $0.00 0.00% 6,261,378 $4.67 $4.72 $4.66
    13 May 2025 $4.70 $-0.05 -1.05% 7,922,788 $4.65 $4.75 $4.61

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    09 Dec 2024 David Koczkar Issued 932,801 $3,609,939
    Issue of securities. 2,314,729 Performance Rights
    25 Nov 2024 David Koczkar Transfer 457,907 $1,712,572
    As advised by the company. Transfer of 457,907 Ordinary Shares from
    David Koczkar to Olive Man Investments Pty
    Ltd
    25 Nov 2024 David Koczkar Transfer 457,907 $1,712,572
    As advised by the company. Transfer of 457,907 Ordinary Shares from
    David Koczkar to Olive Man Investments Pty
    Ltd
    02 Sep 2024 David Koczkar Buy 457,907 $1,827,048
    Conversion of securities.
    02 Sep 2024 David Koczkar Expiry 260,942 $1,041,158
    As advised by the company. Lapsed,1,839,835 Rights
    02 Sep 2024 David Koczkar Exercise 457,907 $1,827,048
    Conversion of securities. 1,381,928 Rights
    26 Aug 2024 Michael (Mike) Wilkins Buy 100,000 $396,000
    On-market trade.
    26 Aug 2024 Kathryn Fagg Buy 32,750 $129,362
    On-market trade.
    26 Aug 2024 Jay Weatherill Buy 5,100 $19,915
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Michael (Mike) John Wilkins Non-Executive DirectorNon-Executive Chairman May 2017
    Mr Wilkins has more than 30 years of experience in financial services, predominantly in Australia and Asia. He is a member of Investment and Capital and People Committee.
    Mrs Linda Bardo Nicholls Non-Executive Director Mar 2014
    Mrs Nicholls has more than 30 years of experience as a senior executive and director in banking, insurance and funds management in Australia, New Zealand and the United States. She is the Chair of the Investment and Capital Committee and also a member of Risk Management Committee.
    Ms Kathryn Joy Fagg Non-Executive Director Mar 2022
    Ms Fagg is a director and Chair with wide-ranging senior commercial and operational experience. She is a member of People Committee.
    Mr David Fagan Non-Executive Director Mar 2014
    Mr Fagan has practised as a commercial lawyer for over 40 years. During that time, he held a variety of leadership positions at Clayton Utz culminating in the role of Chief Executive Partner for 9 years. He is the Chair of the Risk Management Committee.
    Mr David Koczkar Chief Executive OfficerManaging Director May 2021
    Mr Koczkar has more than 25 years of strategy, innovation, commercial and operational experience across Australia, Asia and the UK, including previous work in the consulting and financial services industries.
    Mr Peter Dobie Everingham Non-Executive Director Mar 2022
    Mr Everingham has over 25 years of corporate experience and is highly respected in the digital sector, having held senior executive roles in that sector for 18 years. His senior leadership experience includes key roles at companies with a strong consumer and technology focus. He is a member of People and Investment and Capital Committee.
    Dr Tracey Leigh Batten Non-Executive Director Aug 2017
    Dr Batten has experience in the health services sector, with strong commercial, business and change leadership skills. She is the Chair of the People Committee and also a member of Risk Management Committee.
    Mr Gerard Dalbosco Non-Executive Director May 2021
    Mr Dalbosco held a number of senior leadership roles including Oceania Managing Partner and CEO; Asia Pacific Joint Deputy CEO and Managing Partner-Markets; Oceania Managing Partner-Transaction Advisory Services; and Melbourne Managing Partner. Prior to these roles Gerard advised organisations across a range of sectors in respect of merger and acquisitions advice, valuations, and strategic, commercial and financial due diligence. He is a member of Risk Management Committee.
    Mr Jay Wilson Weatherill Non-Executive Director Mar 2024
    Mr Weatherill has had a career in public office with expertise across a wide range of public policy areas including reform of social services. He is a member of Risk Management Committee.
    Ms Mei Ramsay Group General CounselCompany Secretary Mar 2011
    -
    Mei Ramsay Group General CounselCompany Secretary
    -
    Rob Read Group Lead Amplar Health
    -
    Milosh Milisavljevic Group Lead Chief Customer Officer
    -
    Mark Rogers Group Lead Chief Financial Officer & Group Strategy
    -
    Tom Exton Group Lead Chief Risk & Compliance Officer
    -
    Felicia Trewin Group Lead Data & Technology
    -
    Rob Deeming Group Lead Digital & Ventures
    -
    Kylie Bishop Group Lead People Spaces & Sustainability
    -
    Meaghan Telford Group Lead Policy Advocacy & Reputation
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 897,801,743 32.60%
    J P Morgan Nominees Australia Pty Limited 542,208,525 19.69%
    Citicorp Nominees Pty Limited 320,377,977 11.63%
    National Nominees Limited 81,375,680 2.95%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 71,271,047 2.59%
    BNP Paribas Noms Pty Ltd 46,314,124 1.68%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 21,450,620 0.78%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 20,002,248 0.73%
    HSBC Custody Nominees (Australia) Limited A/C 2 8,980,884 0.33%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 7,590,106 0.28%
    HSBC Custody Nominees (Australia) Limited i 7,343,069 0.27%
    Netwealth Investments Limited <Wrap Services A/C> 6,630,695 0.24%
    IOOF Investment Services Limited <Ips Superfund A/C> 5,169,307 0.19%
    UBS Nominees Pty Ltd 4,975,089 0.18%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 4,961,790 0.18%
    IOOF Investment Services Limited <Iisl Nal Isma 2 A/C> 3,786,900 0.14%
    Bond Street Custodians Limited <Cockej - F01832 A/C> 3,784,143 0.14%
    Ioof Investment Services Limited <Ioof Idps A/C> 3,745,418 0.14%
    Netwealth Investments Limited <Super Services A/C> 3,279,571 0.12%
    Solium Nominees (Australia) Pty Ltd <Vsa A/C> 3,221,313 0.12%

    Profile

    since

    Note